← FDA Drug Approvals (Drugs@FDA)

BUPRENORPHINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2026-10-15

Drug application

FDA Application #
ANDA221145
Application type
Abbreviated New Drug Application (Generic)
Brand name
BUPRENORPHINE HYDROCHLORIDE
Generic name
Buprenorphine Hydrochloride
Active ingredients
BUPRENORPHINE HYDROCHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
GLAND
First approval
2026-10-15

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown